KROS · NASDAQ · Biotechnology

Keros Therapeutics (KROS)

Develops protein therapeutics for neuromuscular disease and blood-cell disorders.

$11.65
vs last close−0.08 (−0.68%)
  1. KROS: Is the Discount Book Value a Value Trap?

    Zacks Investment Research